Amyloid-β (Aβ) and cerebral small vessel disease (CSVD) commonly coexist. They can
occur independently by chance, or may interact with each other. We aimed to determine …

Background: Some patients clinically diagnosed with subcortical vascular cognitive
impairment (SVCI) have co-morbidity with AD pathology. Objective: We investigated …

We investigated the amyloid and vascular burden in Pittsburgh compound B (PiB)–negative
subcortical vascular mild cognitive impairment (svMCI) and PiB-negative subcortical …

Abstract Background Mixed pathology, particularly Alzheimer's disease with cerebrovascular
lesions, is reported as the second most common cause of dementia. Research on mixed …

Objective To evaluate the association between brain amyloid β (Aβ) and cerebral small
vessel disease (CSVD) markers, as well as their joint effect on cognition, in a memory clinic …

Background and purpose Subcortical vascular cognitive impairment (SVCI) is characterized
by the presence of cerebral small vessel disease (CSVD) markers. Some SVCI patients also …

Despite existing criteria, differential diagnosis of Vascular Dementia (VD) and Alzheimer's
disease (AD) remains difficult. The aim of this study is to figure out cognitive and biomarker …

Background To determine the association between amyloid-beta (Aβ) plaque deposition
and changes in global cognition, executive functions, information processing speed, and …

Objective Neuropsychological test-specific neural substrates in subcortical vascular
cognitive impairment (SVCI) are expected to differ from those in Alzheimer's disease-related …

Objective To apply an AT (Aβ/tau) classification system to subcortical vascular cognitive
impairment (SVCI) patients following recently developed biomarker-based criteria of …